Browsing Tag
GlaxoSmithKline
25 posts
Strides Pharma gets FDA approval for Ibuprofen oral suspension
Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has…
June 11, 2022
GSK to acquire vaccine developer Affinivax in deal worth up to $3.3bn
GlaxoSmithKline (GSK) has agreed to acquire Affinivax, a Boston-based clinical-stage vaccine developer, in a deal worth up to…
June 1, 2022
GSK to acquire US biopharma company Sierra Oncology for $1.9bn
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9…
April 23, 2022
GlaxoSmithKline to transfer rights to Iodex and Ostocalcium for Rs 16.5bn
GlaxoSmithKline Pharmaceuticals Limited said that it will transfer its rights pertaining to the Iodex pain relief and Ostocalcium…
July 29, 2021
Dr. Reddy’s Laboratories launches Albendazole Tablets, USP in US
Dr. Reddy’s Laboratories has launched Albendazole Tablets, USP, a generic version of GlaxoSmithKline’s Albenza Tablets, 200 mg, which…
April 30, 2021
ViiV Healthcare’s Cabenuva secures FDA approval for HIV treatment
ViiV Healthcare has received FDA approval for Cabenuva, a long-acting treatment regimen for HIV-1 infection in adult patients.…
January 24, 2021
Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to…
July 30, 2020
Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership
French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine…
April 17, 2020
Unilever wraps up acquisition of Horlicks from GSK, merges HUL and GSKCH
Unilever’s Indian subsidiary Hindustan Unilever Limited (HUL) has wrapped up its previously announced merger of GlaxoSmithKline Consumer Healthcare…
April 3, 2020
ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment
Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine)…
July 14, 2019